4//SEC Filing
Dinarello Charles A 4
Accession 0000914190-18-000041
CIK 0000842023other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:02 PM ET
Size
22.8 KB
Accession
0000914190-18-000041
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Dinarello Charles A
Director
Transactions
- Exercise/Conversion
Common Stock
2018-02-13$65.47/sh+5,000$327,350→ 13,212 total - Sale
Common Stock
2018-02-13$136.36/sh−2,505$341,582→ 8,212 total - Sale
Common Stock
2018-02-13$135.76/sh−2,495$338,721→ 10,717 total - Exercise/Conversion
Stock Option (right to buy)
2018-02-13−5,000→ 0 totalExercise: $65.47From: 2008-10-23Exp: 2018-10-22→ Common Stock (5,000 underlying)
Holdings
- 4,000
Stock Option (right to buy)
Exercise: $91.78From: 2014-10-30Exp: 2024-10-30→ Common Stock (4,000 underlying) - 5,000
Stock Option (right to buy)
Exercise: $61.46From: 2010-10-28Exp: 2020-10-27→ Common Stock (5,000 underlying) - 3,125
Stock Option (right to buy)
Exercise: $125.05Exp: 2027-10-26→ Common Stock (3,125 underlying) - 4,260
Stock Option (right to buy)
Exercise: $87.34From: 2016-10-29Exp: 2025-10-28→ Common Stock (4,260 underlying) - 5,000
Stock Option (right to buy)
Exercise: $70.35From: 2011-10-27Exp: 2021-10-26→ Common Stock (5,000 underlying) - 5,000
Stock Option (right to buy)
Exercise: $63.03From: 2009-10-29Exp: 2019-10-28→ Common Stock (5,000 underlying) - 3,985
Stock Option (right to buy)
Exercise: $101.19From: 2017-10-26Exp: 2026-10-26→ Common Stock (3,985 underlying) - 4,000
Stock Option (right to buy)
Exercise: $87.39From: 2013-10-31Exp: 2023-10-30→ Common Stock (4,000 underlying) - 5,000
Stock Option (right to buy)
Exercise: $66.90From: 2012-10-25Exp: 2022-10-24→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.61 to $135.875, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.03 to $136.66, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The option vests on the earlier of the one year anniversary of the grant date (10/26/17) or the date of Bio-Techne's 2018 annual meeting of shareholders.
Documents
Issuer
BIO-TECHNE Corp
CIK 0000842023
Entity typeother
Related Parties
1- filerCIK 0001344987
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:02 PM ET
- Size
- 22.8 KB